Used primarily in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It serves as a structural analog in developing compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its scaffold supports binding affinity and selectivity for central nervous system receptors, making it valuable in optimizing drug candidates for cognitive enhancement and neuroprotection. Also employed in medicinal chemistry for structure-activity relationship (SAR) studies to improve metabolic stability and bioavailability of related therapeutics.